NEW YORK, May 26, 2011 /PRNewswire/ -- SuperGen, Inc.
(NASDAQ: SUPG), a pharmaceutical company dedicated to the discovery
and development of novel cancer therapies, today announced that
James S.J. Manuso, Ph.D., president
and chief executive officer, will present at
RetailInvestorConferences.com.
DATE: June 2nd, 2011
TIME: 10:00AM EDT
LINK: www.retailinvestorconferences.com> Click the red
"register/ watch event now" button.
This will be a live, interactive online event where investors
are invited to ask the company questions in real-time both in the
presentation hall as well as the company's "virtual trade booth."
If attendees are not able to join the event live in real-time, an
on-demand archive will be available for 90 days.
It is recommended that investors pre-register to save time and
receive event updates.
About SuperGen
SuperGen is a pharmaceutical company dedicated to discovery and
development of novel cancer therapeutics in epigenetic and cell
signaling modulation. The Company develops products through
biochemical and clinical proof of concept to partner for further
development and commercialization. On April
6, 2011, SuperGen entered into a definitive merger agreement
to acquire Astex Therapeutics Limited, a UK based biotechnology
company. The transaction is subject to customary regulatory, legal
and shareholder approvals. For more information about SuperGen,
please visit http://www.supergen.com.
About RetailInvestorConferences.com
RetailInvestorConferences.com, created by BetterInvesting
(NAIC), PR Newswire and MUNCmedia, is the first monthly
virtual investor conference series that provides an interactive
forum for presenting companies to meet directly with retail
investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based
investor conferences, Retail Investor Conferences unites PR
Newswire's leading-edge online conferencing and investor
communications capabilities with BetterInvesting's extensive retail
investor audience network and MUNCmedia's sophisticated retail
investor targeting.
SOURCE SuperGen